Drug intelligence / Profile preview

Iroson-F

Development stage
Unknown
Lead developer
Obsons Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Iroson-F is an oral combination therapy developed by Obsons Pharmaceuticals, containing iron polymaltose (elemental iron) and folic acid (vitamin B9). It is approved and marketed in Pakistan in both tablet and syrup formulations for the prevention and treatment of iron deficiency anemia and latent iron deficiency, particularly during pregnancy, lactation, and periods of rapid growth. Iron polymaltose provides a stable, non-ionic source of iron that is gradually absorbed in the small intestine and delivered to transferrin and ferritin for hemoglobin synthesis, minimizing gastrointestinal side effects compared to traditional ferrous salts. Folic acid is converted by dihydrofolate reductase into active tetrahydrofolate cofactors, which are essential for DNA synthesis, red blood cell production, and the prevention of neural tube defects.

Brand names
Iroson -FIroson-FIroson-F SyrupIroson-F Tablet
Other names
Elemental Iron + Folic AcidIron Polymaltose + Folic AcidIron polymaltose and folic acid
02

Targets

DHFR (Dihydrofolate reductase)FOLR1 (FRα)

Beyond the preview

Go deeper on Iroson-F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iroson-F.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call